Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 19th Jul 2018 16:19

Friday 20 July 
Acacia MiningHalf Year Results 
BeazleyHalf Year Results 
KCOM GroupTrading Statement 
HomeserveTrading Statement 
RecordTrading Statement 
Monday 23 July 
Ryanair HoldingsQ1 Results
AscentialHalf Year Results 
McColl's Retail GroupHalf Year Results 
TungstenFull Year Results 
Paragon Banking GroupTrading Statement 
MicrogenHalf Year Results 
SthreeHalf Year Results 
JTCTrading Statement 
Tuesday 24 July 
IG Group HoldingsFull Year Results
Drax GroupHalf Year Results 
Fevertree Drinks Half Year Results 
Gresham Technologies Half Year Results 
PZ CussonsFull Year Results
SpectrisHalf Year Results 
Victoria Full Year Results
Centaur Media Half Year Results 
HammersonHalf Year Results 
HuntsworthHalf Year Results 
Unite GroupHalf Year Results 
BritvicTrading Statement 
Wednesday 25 July 
GlaxoSmithKlineHalf Year Results (at 1200 BST)
Vodafone GroupTrading Statement 
Joules GroupFull Year Results 
Wizz AirQ1 Results 
Staffline GroupHalf Year Results 
QuartixHalf Year Results 
IndiviorHalf Year Results 
Burford CapitalHalf Year Results 
Fulham ShoreHalf Year Results 
IDOXHalf Year Results 
IP GroupHalf Year Results 
QinetiQQ1 Results 
Capital & Counties PropertiesHalf Year Results 
InformaHalf Year Results 
Croda InternationalHalf Year Results 
TymanHalf Year Results 
Rathbone BrothersHalf Year Results 
VictrexHalf Year Results 
3i GroupTrading Statement 
AntofagastaQ2 Production
Brewin DolphinTrading Statement 
FresnilloQ2 Production
International Personal FinanceHalf Year Results 
ITVHalf Year Results 
Marston'sTrading Statement 
Metro BankHalf Year Results 
Tullow OilHalf Year Results 
Primary Health PropertiesHalf Year Results 
Thursday 26 July 
Royal Dutch ShellHalf Year Results
SchrodersHalf Year Results
Intu PropertiesHalf Year Results
Howden Joinery Group Half Year Results
EvrazTrading Statement 
Discoverie Group Trading Statement 
Intermediate Capital GroupTrading Statement 
Law Debenture CorpHalf Year Results
SEGRO Half Year Results
Virgin MoneyHalf Year Results
Sage Group Trading Statement 
Compass GroupTrading Statement 
PayPointTrading Statement 
Tarsus Group Half Year Results
Anglo American Half Year Results
AstraZenecaHalf Year Results
BodycoteHalf Year Results
British American TobaccoHalf Year Results
Countrywide Half Year Results
Daily Mail & General Trust ATrading Statement 
DiageoFull Year Results
Impellam GroupHalf Year Results
Inchcape Half Year Results
Jardine Lloyd Thompson GroupHalf Year Results
KAZ Minerals Q2 Production
Sophos Q1 Results
Lancashire HoldingsHalf Year Results
National Express GroupHalf Year Results
RELX Half Year Results
RenishawFull Year Results
Smith & Nephew Half Year Results
Tate & LyleTrading Statement 
Vesuvius Half Year Results
Morgan Advanced Materials Half Year Results
Countryside PropertiesQ3 Results
Franchise BrandsHalf Year Results
CMC MarketsTrading Statement 
Polymetal InternationalQ2 Production
AVEVA GroupTrading Statement 
  

More News
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.